Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors

Metformin is a widely used antidiabetic drug, and epidemiology studies for pancreatic and other cancers indicate that metformin exhibits both chemopreventive and chemotherapeutic activities. Several metformin-induced responses and genes are similar to those observed after knockdown of specificity pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nair, Vijayalekshmi, Pathi, Satya, Jutooru, Indira, Sreevalsan, Sandeep, Basha, Riyaz, Abdelrahim, Maen, Samudio, Ismael, Safe, Stephen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Original Manuscript
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845888/
https://ncbi.nlm.nih.gov/pubmed/23803693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgt231
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak